|
Volumn 14, Issue 4, 2000, Pages 925-938
|
Simulation modeling of outcomes and cost effectiveness
a,b a,c a a,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALTRETAMINE;
ANTINEOPLASTIC AGENT;
CARCINOEMBRYONIC ANTIGEN;
CISPLATIN;
IFOSFAMIDE;
PACLITAXEL;
PROSTATE SPECIFIC ANTIGEN;
TAMOXIFEN;
TUMOR ANTIGEN;
CANCER;
CANCER DIAGNOSIS;
COST EFFECTIVENESS ANALYSIS;
HUMAN;
LUNG CANCER;
MATHEMATICAL MODEL;
MEDICAL DECISION MAKING;
MULTIMODALITY CANCER THERAPY;
NONHODGKIN LYMPHOMA;
OUTCOMES RESEARCH;
OVARY CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
REVIEW;
|
EID: 0033887389
PISSN: 08898588
EISSN: None
Source Type: Journal
DOI: 10.1016/S0889-8588(05)70319-1 Document Type: Article |
Times cited : (32)
|
References (32)
|